Sign in
Cancer BiologybioRxiv
Preprint

Oncogenic Ras-Src-cortactin signaling rewires actin-generated forces to drive basement membrane rupture and initiate breast cancer invasion

Eric Platz‐BaudiniD, Julian EschenbruchiD, Yannick HerfsiD, Georg DreisseniD, Ronald Wein, Emiel P. C. van der VorstiD, Michael RoseiD, Rudolf MerkeliD, Erik NoetzeliD

Abstract

Oncogenic HRas activation plays a fundamental role in tumorigenesis, yet the cellular mechanisms by which HRas downstream signaling drives basement membrane (BM) disruption during early breast cancer invasion remain unclear. Using HRas-inducible breast spheroids, we demonstrate that HRas rewires cellular mechanotransduction of tumor-associated extracellular matrix stiffening to promote invasion. This process occurs independently of canonical myosin II-mediated contractility and proteolytic BM degradation. Transcriptomic and kinome profiling identified an HRas-Src-cortactin-Arp2/3 signaling axis that generates disruptive mechanical BM stress. We describe cortical triplet (CT) structures, defined by cortactin-dependent actin reinforcement and localized BM loss. CTs integrate increased cortical tension, actin polymerization forces, and myosin I-dependent contractility, thereby predicting invasion events. Pharmacological inhibition of Src or Arp2/3 reduced CT formation and invasion. Furthermore, elevated expression of HRas-cortactin-Arp2/3 axis components correlated with poor patient survival. Together, these findings uncover a previously unrecognized mechanism of early breast cancer invasion and highlight potential therapeutic targets.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISChang '22Si '22Thomas '18Saraswathib '25Kim '19Net '26
72% semantic matchCancer Biology
J. Chang, A. Saraswathibhatla, Z. Song+10 more·bioRxiv·Jul 28, 2022